In vitro study for the evaluation of transluminal aspiration as a novel treatment option for thrombosis in the HeartWare HVAD

Abstract

Introduction:

Pump thrombosis of left ventricular assist devices remains a devastating complication with high morbidity and mortality. Despite the improvements made, the matter affects many patients and the treatment options are limited to thrombolysis and surgical replacement. An alternative approach using the aspiration Indigo catheter was tested.

Methods:

An Indigo thrombectomy catheter was used within an in vitro model to assess the direct aspiration of prefabricated clots from three different positions within the HeartWare HVAD (inlet, outlet, and housing). The experiments were conducted with a straight and an angled catheter. The aspiration pressure was constant. The flow, power consumption, and pressure head of the left ventricular assist devices were measured at pre-defined measuring points.

Results:

The device was more effective (success rate 71%) at inlet and outlet of the left ventricular assist device. In addition, the duration of aspiration and the aspiration volume were shorter in comparison to the aspiration in the housing (inlet M = 19.75 s, outlet M = 60.50 s, and housing M = 38.75 s). Moreover, the aspiration volume was associated with the aspiration duration and the weight of thrombi but not with their volume. Noteworthy, the angled catheter showed an improved performance compared to the straight one (67%–33%). The recorded parameters showed no major changes during the use of the catheter. After application of the Indigo catheter, flow and pressure head of the pump could be restored.

Conclusions:

The aspiration system showed promising results under specific conditions for the treatment of pump thrombosis in an in vitro model. However, further examination, including in vivo experiments, will justify its effectiveness.

Keywords

Pump thrombosis ventricular assist device left ventricular assist device HVAD aspiration mechanical thrombectomy Indigo

Get full access to this article

View all access options for this article.

References

Bartoli

Ailawadi

Kern

. Diagnosis, nonsurgical management, and prevention of LVAD thrombosis. J Card Surg 2014; 29: 83–94.

Jennings

Weeks

. Thrombosis in continuous-flow left ventricular assist devices: pathophysiology, prevention, and pharmacologic management. Pharmacotherapy 2015; 35(1): 79–98.

Hanke

Rojas

Mahr

et al . Five-year results of patients supported by HeartMate II: outcomes and adverse events. Eur J Cardiothorac Surg 2018; 53: 422–427.

Kirklin

Pagani

Kormos

et al . Eighth annual INTERMACS report: special focus on framing the impact of adverse events. J Heart Lung Transplant 2017; 36: 1080–1086.

Rajwal

Richards

O’Meara

. The use of recalcified citrated whole blood—a pragmatic approach for thromboelastography in children. Paediatr Anaesth 2004; 14: 656–660.

Prasad

Robertson

Itoh

et al . Histologic analysis of clots in explanted axial continuous-flow left ventricular assist devices. J Heart Lung Transplant 2015; 34(4): 616–618.

Blitz

. Pump thrombosis—a riddle wrapped in a mystery inside an enigma. Ann Cardiothorac Surg 2014; 3(5): 450–471.

Goldstein

John

Salerno

et al . Algorithm for the diagnosis and management of suspected pump thrombus. J Heart Lung Transplant 2013; 32(7): 667–670.

Scandroglio

Kaufmann

Pieri

et al . Diagnosis and treatment algorithm for blood flow obstructions in patients with left ventricular assist device. J Am Coll Cardiol 2016; 67(23): 2758–2768.

10.

Stulak

Dunlay

Sharma

et al . Treatment of device thrombus in the HeartWare HVAD: success and outcomes depend significantly on the initial treatment strategy. J Heart Lung Transplant 2015; 34(12): 1535–1541.

11.

Hanke

Rojas

Dogan

et al . First series of left ventricular assist device exchanges to HeartMate 3. Eur J Cardiothorac Surg 2017; 51: 887–892.

12.

Schmitto

Molitoris

Haverich

et al . Implantation of a centrifugal pump as a left ventricular assist device through a novel, minimized approach: Upper hemisternotomy combined with anterolateral thoracotomy. J Thorac Cardiovasc Surg 2012; 143(2): 511–513.

13.

Schmitto

Hanke

Rojas

et al . First implantation in man of a new magnetically levitated left ventricular assist device (HeartMate III). J Heart Lung Transplant 2015; 34(6): 858–860.

14.

Schmitto

Rojas

Haverich

. Left ventricular assist devices for advanced heart failure. N Engl J Med 2017; 376(19): 1894–1895.

15.

Netuka

Sood

Pya

et al . Fully magnetically levitated left ventricular assist system for treating advanced HF. J Am Coll Cardiol 2015; 66(23): 2579–2589.

16.

Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009; 40: 2761–2768.

17.

Benenati

Saxon

Teigen

et al . Penumbra/Indigo system provides a novel aspiration thrombectomy tool in treatment of peripheral and visceral arterial occlusions: final results of the PRISM trial. J Vasc Interv Radiol 2016; 27(3): 96–97.

18.

Bisdas

Stavroulakis

Beropoulis

et al . Initial experience with the 6-F and 8-F Indigo thrombectomy system for acute renovisceral occlusive events. J Endovasc Ther 2017; 24(4): 604–610.

19.

Ciampi-Dopazo

Romeu-Prieto

Sánchez-Casado

et al . Aspiration thrombectomy for treatment of acute massive and submassive pulmonary embolism: initial single-center prospective experience. J Vasc Interv Radiol 2017; 29(1): 101–106.

20.

Kaufmann

Hörmandinger

Stepanenko

et al . Acoustic spectral analysis for determining pump thrombosis in rotary blood pumps. ASAIO J 2014; 60(5): 502–507.

21.

Birati

Rame

. Diagnosis and management of LVAD thrombosis. Curr Treat Options Cardiovasc Med 2015; 17(2): 361.